Chapter 1. LIFESTYLE DRUGS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. LIFESTYLE DRUGS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. LIFESTYLE DRUGS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. LIFESTYLE DRUGS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. LIFESTYLE DRUGS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. LIFESTYLE DRUGS MARKET– By Form

6.1. Tablets

6.2. Gels

6.3. Parenteral

6.4. Oral Syrups

6.5. Other Forms

Chapter 7. LIFESTYLE DRUGS MARKET– By Therapeutic Type

7.1. Dermatology

7.2. Insomnia

7.3. Obesity

7.4. Sexual Dysfunction

7.5. Others

Chapter 8. LIFESTYLE DRUGS MARKET– By Distribution Channel

8.1. Hospital Pharmacies

8.2. Retail Pharmacies

8.3. Online Channels

Chapter 9. LIFESTYLE DRUGS MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. LIFESTYLE DRUGS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10